id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-E-3278-0012,FDA,FDA-2019-E-3278,Notice of Final Determination,Other,Letter(s),2024-03-22T04:00:00Z,2024,3,2024-03-22T04:00:00Z,,2024-03-22T17:47:43Z,,0,0,090000648648caf1
FDA-2019-E-3278-0013,FDA,FDA-2019-E-3278,Response to Request for Information Pursuant to 37 C.F.R. 1.750,Other,Letter(s),2024-03-14T04:00:00Z,2024,3,2024-09-18T04:00:00Z,,2024-09-18T18:42:43Z,,0,0,090000648648cbb3
FDA-2019-E-3278-0011,FDA,FDA-2019-E-3278,Letter to U.S. Patent and Trademark Office,Other,Letter(s),2024-03-13T04:00:00Z,2024,3,2024-03-13T04:00:00Z,,2024-03-13T17:59:00Z,,0,0,09000064864795a4
FDA-2019-E-3278-0010,FDA,FDA-2019-E-3278,Requirement for Information Letter from U.S. Patent and Trademark Office to Merck & Co. Inc.,Other,Letter(s),2024-02-28T05:00:00Z,2024,2,2024-02-28T05:00:00Z,,2024-03-13T17:52:22Z,,0,0,090000648641eab3
FDA-2019-E-3278-0009,FDA,FDA-2019-E-3278,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2024-01-10T05:00:00Z,2024,1,2024-01-10T05:00:00Z,,2024-03-13T17:52:04Z,,0,0,0900006486389509